AstraZeneca

AstraZeneca

Posted via Workday

AI Research Lead, AI for Oncology Clinical Development

Apply by Oct 12, 2026

Posted Sep 29, 2026

Role at a glance

Job function
AI & Data AI Research & Applied Science
Salary
Not Disclosed
Location
Spain, Barcelona
Work arrangement
On-site
Employment
Full-time
Experience
2-5 years’ work experience outside of PhD with measurable impact (e.g. models delivered, patents, SaMD filings, first-author...
Education
PhD in a quantitative discipline such as computer science, bioinformatics, computational biology, mathematics, physics, biophysics,...

Spotted an issue?

We’ll check it against the original posting.

Log in to report

Role Summary

AI-generated

The Associate Director leads AI research and engineering for oncology clinical development, working across early- and late-phase development and partnering with clinical, biometrics, regulatory, and study teams. The role is based in Barcelona and requires at least three days per week on-site.

What You'll Do

  • Co-own and evolve the AI strategy and roadmap for oncology clinical development.
  • Lead technical delivery and develop or evaluate AI methods, from problem framing and data readiness through validation and deployment.
  • Partner with clinical and study teams to integrate AI solutions into study design, execution, portfolio strategy, and decision-making.
  • Design evaluation frameworks, benchmarking protocols, and calibration plans for model reliability, interpretability, and fitness for...
  • Build external collaborations, represent the organization at scientific conferences and standards bodies, and contribute publications.
  • Mentor peers and scale study-level results into reusable platforms and playbooks.

Generated from the employer's posting. Verify important details before applying.

View full posting

Qualifications

Requires a PhD in a quantitative discipline, 2–5 years of work experience outside the PhD with measurable impact, exceptional software development and coding skills leveraging frontier coding agent frameworks, and deep understanding of machine learning fundamentals with expertise in one or more of: training and tuning foundation models, Bayesian inference, temporal modeling, multimodal integration and modeling, model calibration and domain adaptation, data-centric AI and dataset curation, model and data evaluation and benchmarking, interpretability, or post-training and alignment.

Required

  • preferred

Preferred

  • Knowledge of computing hardware is a plus.
  • Deep expertise in cancer biology.
  • Experience with biological data such as molecular data (DNA, RNA, protein), imaging (radiology, microscopy), or clinical text (EHR,...
  • Experience in drug development, including clinical trial design, biomarker discovery, companion diagnostics, dosing, safety, endpoints,...
  • Experience in a matrixed global organization spanning multiple sites and therapy areas.
  • Proficiency in augmenting, but not supplanting, daily knowledge work with agentic tools.
  • Team-oriented mindset; ability to proactively and independently deliver high-quality contributions at pace.
  • Up-to-date with AI research and tools, proactively trying those of interest, and able to discern hype from added value.

Original job description

Content provided by the employer

This is an in-office role based in Barcelona, ES, with a requirement to work a minimum of three days per week on-site. Remote or travel flexibility is not available.


Are you ready to harness advanced AI to redesign how oncology trials are conceived, executed, and learned from? In this Associate Director role, you will lead high-impact AI research and engineering that reduces patient burden, increases trial efficiency, and sharpens decision-making in late-stage development. Your work will directly influence study design, dosing strategies, endpoints, and safety evaluations, accelerating the delivery of safe, effective medicines to people with cancer.


You will operate at the intersection of AI, clinical science, and cancer biology, partnering across hematology, cell therapy, antibody-drug conjugates, small molecules, and biologics. Based in Barcelona, you will collaborate with global teams to define the questions that matter most, build models that answer them, and translate those models into clinical and regulatory realities. What could you achieve if your models were deployed where decisions are made?


Accountabilities

  • AI Strategy and Roadmap: Co-own and evolve the AI strategy for early and late-phase oncology clinical development, aligning investments to the highest-value opportunities and setting a clear path from research to adoption
  • Technical Leadership: Serve as the principal technical lead within matrixed teams, delivering complex, high-stakes AI programs on time and to a standard that withstands scientific and regulatory scrutiny
  • Method Innovation: Evaluate and develop cutting-edge AI methods across problem framing, data readiness, governance, algorithm development, validation, and deployment; select the right tool for the right question
  • Clinical Partnership: Partner with clinical development, biometrics, regulatory, and study teams to embed novel AI solutions into study design, operational execution, portfolio strategy, and go/no-go decision-making
  • Evidence and Validation: Design rigorous evaluation frameworks, benchmarking protocols, and calibration plans to ensure models are reliable, interpretable, and fit for purpose in real-world clinical contexts
  • External Ecosystem: Build and maintain collaborations with leading academic groups, technology partners, and industry consortia to access novel capabilities and shape standards that matter to oncology development
  • Scientific Leadership: Represent AstraZeneca at scientific conferences and standards bodies; author first- or last-author publications in leading ML and clinical AI journals to advance the field and our influence
  • Team Development: Mentor and support peers, fostering a culture of curiosity, pragmatic engineering, fast prototyping, and learning in public
  • Impact Progression: Deliver near-term wins by solving defined study and program needs; scale insights into reusable platforms and playbooks that raise the bar across the portfolio

Essential Skills/Experience

  • PhD in a quantitative discipline such as computer science, bioinformatics, computational biology, mathematics, physics, biophysics, computational neuroscience, biostatistics
  • 2-5 years’ work experience outside of PhD with measurable impact (e.g. models delivered, patents, SaMD filings, first-author publications, open-source projects, standards-body participation)
  • Exceptional software development and coding skills, leveraging frontier coding agent frameworks; knowledge of computing hardware a plus
  • Deep understanding of machine learning fundamentals, with domain expertise in one or more of the following
  • Training and tuning foundation models.
  • Bayesian inference
  • Temporal modeling
  • Multimodal integration and modeling
  • Model calibration and domain adaptation
  • Data-centric AI: acquiring, creating, and curating datasets for model training / post-training / benchmarking / evals
  • Model and data evaluations and benchmarking
  • Model interpretability
  • Model post-training and alignment


Desirable Skills/Experience

  • Deep expertise in cancer biology
  • Experience working with biological data such as molecular (e.g. DNA, RNA, protein), imaging (radiology, microscopy), or clinical text (e.g. EHR, clinical notes)
  • Experience in drug development including but not limited to clinical trial design, biomarker discovery, companion diagnostics, dosing, safety, endpoints, and regulatory
  • Experience in a matrixed global organization spanning multiple sites and therapy areas
  • Strong proficiency in augmenting but not supplanting daily knowledge work with agentic tools
  • Team-oriented mindset
  • Ability to proactively and independently deliver high-quality contributions at pace
  • Up-to-date with the latest AI research and tools, proactively trying out those of interest, and ability to discern hype from true added value
  • Comfort with ambiguity and a mindset to learn in public, prototype early, and fail forward

Why AstraZeneca

Join a company where digital and data are embedded across the full journey from discovery to the clinic, and where AI is used to make trials smarter, faster, and kinder to patients. You will work with clinicians, statisticians, engineers, and product leaders in the same room, turning bold ideas into systems that influence pivotal studies. We value kindness alongside ambition, back experimentation with resources and governance, and equip you with modern tools to push the boundaries of what clinical AI can do. Your contribution will not sit on a shelf; it will inform real decisions, shape a next-generation pipeline, and help reimagine how care reaches patients.


#EAI

Date Posted

28-sept-2026

Closing Date

11-oct-2026

AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.

AstraZeneca

About the company

AstraZeneca

Large Enterprise

AstraZeneca is a global biopharmaceutical company dedicated to the research, development, and commercialization of innovative medicines. Headquartered in Cambridge, UK, the company focuses on areas such as oncology, cardiovascular, renal, metabolism, and respiratory diseases, striving to deliver life-changing treatments to patients. With a strong commitment to scientific excellence and collaboration, AstraZeneca invests in cutting-edge technologies and partnerships to drive advancements in healthcare. The company is also committed to sustainability and corporate responsibility, aiming to make a positive impact on communities worldwide.